Form 4 for FATE FATE THERAPEUTICS INC
Accepted 2021-07-26 00:00:00 ET · period of report 2021-07-22 · accession 0000899243-21-029868 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2021-07-26 | 2021-07-22+ | FATE | Wolchko J Scott | Pres, CEO, Dir | S - Sale+OE | $85.66 | -60.0K | 417.2K | -13% | -$5.14M |
| DM | 2021-07-26 | 2021-07-22+ | FATE | Wolchko J Scott | Pres, CEO, Dir | M - OptEx | $3.43 | +60.0K | 423.8K | +16% | +$206.0K |
| DM | 2021-07-26 | 2021-07-22+ | FATE | Wolchko J Scott | Pres, CEO, Dir | M - OptEx | $0.00 | -60.0K | 100.0K | -38% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2021-07-23 | S | D | 30,000 | $85.28 | 393,793 | D | — | — | |
| 2 | Common | Common Stock | 2021-07-23 | M | A | 20,000 | $4.84 | 423,793 | D | — | — | |
| 3 | Common | Common Stock | 2021-07-23 | M | A | 10,000 | $2.73 | 403,793 | D | — | — | |
| 4 | Common | Common Stock | 2021-07-22 | S | D | 1,600 | $86.90 | 393,793 | D | — | — | (F4) Represents the weighted average sale price of the shares sold ranging from $86.76 to $87.15 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price. |
| 5 | Common | Common Stock | 2021-07-22 | S | D | 21,773 | $86.19 | 395,393 | D | — | — | (F3) Represents the weighted average sale price of the shares sold ranging from $85.76 to $86.75 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price. |
| 6 | Common | Common Stock | 2021-07-22 | S | D | 6,627 | $85.38 | 417,166 | D | — | — | (F2) Represents the weighted average sale price of the shares sold ranging from $84.76 to $85.74 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each price. |
| 7 | Common | Common Stock | 2021-07-22 | M | A | 30,000 | $2.73 | 423,793 | D | — | — | |
| 8 | Derivative | Stock Option (Right to Buy) | 2021-07-23 | M | D | 10,000 | $0.00 | 90,000 | D | $2.73 · — to 2027-01-03 | 10,000 Common Stock | (F5) This option is fully vested. |
| 9 | Derivative | Stock Option (Right to Buy) | 2021-07-23 | M | D | 20,000 | $0.00 | 24,846 | D | $4.84 · — to 2025-01-04 | 20,000 Common Stock | (F5) This option is fully vested. |
| 10 | Derivative | Stock Option (Right to Buy) | 2021-07-22 | M | D | 30,000 | $0.00 | 100,000 | D | $2.73 · — to 2027-01-03 | 30,000 Common Stock | (F5) This option is fully vested. |